Investor Overview

There are currently no events to display.

Global - Overview

Aimmune Therapeutics, Inc., is a biopharmaceutical company developing oral treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to provide meaningful levels of protection against allergic reactions resulting from exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune’s first investigational, complex biologic product, AR101, is being developed as a treatment to reduce the frequency and severity and ... more >

Recent News

more >

Upcoming Events

more >
There are currently no events to display.

Past Events

Show events starting after a certain date ( i.e. YYYY-MM-DD)
  • Webcast Image Webcast
    J.P. Morgan Healthcare Conference Breakout Session
    January 10, 2018
    8:00 AM PST
  • Webcast Image Webcast
    Aimmune Therapeutics Conference Call
    February 20, 2018
    5:00 AM PST
  • Webcast Image Webcast
    Aimmune Analyst and Investor Event at AAAAI-WAO
    March 04, 2018
    6:30 PM EST
  • Webcast Image Webcast
    Cowen and Company 38th Annual Health Care Conference
    March 13, 2018
    8:00 AM EDT
  • Webcast Image Webcast
    Barclays Global Healthcare Conference
    March 14, 2018
    11:15 AM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics at 17th Annual Needham Healthcare Conference
    March 27, 2018
    4:30 PM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics at Bank of America Merrill Lynch Healthcare Conference
    May 16, 2018
    1:40 PM PDT
  • Webcast Image Webcast
    Aimmune Therapeutics at Jefferies Global Healthcare Conference
    June 05, 2018
    3:30 PM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics at Nasdaq 38th Investor Conference
    June 12, 2018
    12:00 AM PDT
  • Webcast Image Webcast
    Aimmune Therapeutics at JMP Securities Life Sciences Conference
    June 20, 2018